1、IGF2BP2 regulates DANCR by serving as an N6-methyladenosine Reader,Hu Xiao Ge,Yang L,Cell Death Differ,SCI,2020-06,Zhejiang Provincial People’s Hospital,一区,15.828,1782-1794
2、A Neoantigen-Based Peptide Vaccine for Patients With Advanced Pancreatic Cancer Refractory to Standard Treatment,Chen Zhe ling,Yang L,Front Immunol,SCI,2021-08,Zhejiang Provincial People’s Hospital,二区,7.561,12:691605
3、lncRNA RMST Enhances DNMT3 Expression through Interaction with HuR,Peng Wan xin,Yang L,Mol Ther,SCI,2020-01,Zhejiang Provincial People’s Hospital,一区,11.454,9-18
4、LINC00346 promotes pancreatic cancer progression through the CTCF-mediated Myc transcription,Peng Wan xin,Yang L,Oncogene,SCI,2019-01,Zhejiang Provincial People’s Hospital,一区,9.867,6770-6780
5、Circulating Tumor DNA as a Potential Marker to Detect Minimal Residual Disease and Predict Recurrence in Pancreatic Cancer,Jiang Jia Hong,Yang L,Front Oncol,SCI,2020-07,Zhejiang Provincial People’s Hospital,三区,6.244,10:1220.
6、KLF4 p.A472D Mutation Contributes to Acquired Resistance to Cetuximab in Colorectal Cancer,Song Y,Yang L,Mol Cancer Ther,SCI,2020-03,Zhejiang Provincial People’s Hospital,二区,6.261,956-965
7、Exome capture sequencing of adenoma reveals genetic alterations in multiple cellular pathways at the early stage of colorectal tumorigenesis,Yang L,Zheng S,PLoS One,SCI,2013-11,Zhejiang University School of Medicine,三区,2.766,e53310
8、Accumulating evidence: TLR signaling facilitates the development of hepatocellular carcinoma,Yang L,Dong Sheng Huang,Int J Clin Exp Med,SCI,2016-05,Zhejiang Provincial People’s Hospital,四区,0.181,4107-4112
9、Pharmacokinetics and safety of cyclophosphamide and docetaxel in hemodialysis patient with early stage breast cancer: a case report,Yang L,Shen P,BMC Cancer,SCI,2015-12,Zhejiang University School of Medicine,三区,2.933,917
10、A Novel WRN Frameshift Mutation Identified by Multiplex Genetic Testing in a Family with Multiple Cases of Cancer,Yang L,Zheng S,PLoS One,SCI,2015-04,Zhejiang University School of Medicine,三区,2.766,e0133020
11、Efficacy and Safety Profile of Celecoxib for Treating Advanced Cancers: A Meta- Analysis of 11 Randomized Clinical Trials,Chen J,Yang L,Clin Ther,SCI,2014-04,Zhejiang University School of Medicine,三区,2.935,1253-63
12、TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma,Song Ye,Yang L,ONCOLOGY REPORTS,SCI,2017-07,Zhejiang Provincial People’s Hospital,三区,2.976,2215-2226
13、Liquid Biopsy for Cancer: Circulating Tumor Cells, Circulating Free DNA or Exosomes,Zhang W,Yang L,Cell Physiol Biochem,SCI,2017-06,Zhejiang Provincial People’s Hospital,二区,5.5,755–768
14、IGF2BP2 promotes colorectal cancer cell proliferation and survival through interfering with RAF-1 degradation by miR-195,Ye S,Yang L,FEBS Lett,SCI,2016-06,Zhejiang University School of Medicine,三区,2.675,1641-50
15、Deep sequencing reveals the molecular pathology characteristics between primary uterine leiomyoma and pulmonary benign metastasizing leiomyoma,Jiang J,Yang L,Clin Transl Oncol,SCI,2018-08,Zhejiang Provincial People’s Hospital,三区,2.441,1080-1086
16、The effect of aspirin on circulating tumor cells in metastatic colorectal and breast cancer patients: a phase II trial study,Yang L,Ni C,Clin Transl Oncol,SCI,2018-07,Zhejiang Provincial People’s Hospital,三区,2.441,912-921
17、Aspirin to inhibit the formation and EMT of circulating tumor cells in patients with metastatic colorectal cancer but not breast cancer,Chao Ni,Yang L,J Clin Oncol,SCI,2017-06,Zhejiang Provincial People’s Hospital,一区,28.245,e23024
18、Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma,Yang L,Huang J,J Cancer,SCI,2018-12,Zhejiang Provincial People’s Hospital,三区,3.182,3225-3235
19、Prospects of Noncoding RNAs in Hepatocellular Carcinoma,Zhou H,Yang L,Biomed Res Int,SCI,2018-07,Zhejiang Provincial People’s Hospital,三区,2.197,6579436
20、A Systematic Review of Long Noncoding RNAs in Hepatocellular Carcinoma: Molecular Mechanism and Clinical Implications,Hu X,Yang L,Biomed Res Int,SCI,2018-09,Zhejiang Provincial People’s Hospital,三区,2.197,8126208
21、The tumor suppressive miR-302c-3p inhibits migration and invasion of hepatocellular carcinoma cells by targeting TRAF4,Yang L,Xu Q,J Cancer,SCI,2018-06,Zhejiang Provincial People’s Hospital,三区,3.182,2693-2701
22、Mutation profiling of cancer and stromal cells from patients with pancreatic ductal adenocarcinoma,Yang L,Dongsheng Huang,J Clin Oncol,SCI,2018-06,Zhejiang Provincial People’s Hospital,一区,28.245,e16238
23、KLF4 p.A472D mutation: An acquired resistant mutation to cetuximab in colorectal cancer,Yang L,Dongsheng Huang,J Clin Oncol,SCI,2019-02,Zhejiang Provincial People’s Hospital,一区,28.245,e15077
24、A Neoantigen-Based Peptide Vaccine for Patients With Advanced Pancreatic Cancer Refractory to Standard Treatment,Chen Zhe ling,Yang L,Front Immunol,SCI,2021-08,Zhejiang Provincial People’s Hospital,二区,7.561,12:691605
25、lncRNA RMST Enhances DNMT3 Expression through Interaction with HuR,Peng Wan xin,Yang L,Mol Ther,SCI,2020-01,Zhejiang Provincial People’s Hospital,一区,11.454,9-18
26、LINC00346 promotes pancreatic cancer progression through the CTCF-mediated Myc transcription,Peng Wan xin,Yang L,Oncogene,SCI,2019-01,Zhejiang Provincial People’s Hospital,一区,9.867,6770-6780
27、Circulating Tumor DNA as a Potential Marker to Detect Minimal Residual Disease and Predict Recurrence in Pancreatic Cancer,Jiang Jia Hong,Yang L,Front Oncol,SCI,2020-07,Zhejiang Provincial People’s Hospital,二区,6.244,10:1220.
28、KLF4 p.A472D Mutation Contributes to Acquired Resistance to Cetuximab in Colorectal Cancer,Song Y,Yang L,Mol Cancer Ther,SCI,2020-03,Zhejiang Provincial People’s Hospital,二区,6.261,956-965
29、A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis,Yang L,Kangsheng Tu,Mol Cancer,SCI,2019-10,Zhejiang Provincial People’s Hospital,二区,10.679,28
|